BE866611A - Medicament contre les maladies de la peau - Google Patents

Medicament contre les maladies de la peau

Info

Publication number
BE866611A
BE866611A BE187311A BE187311A BE866611A BE 866611 A BE866611 A BE 866611A BE 187311 A BE187311 A BE 187311A BE 187311 A BE187311 A BE 187311A BE 866611 A BE866611 A BE 866611A
Authority
BE
Belgium
Prior art keywords
medicine
skin diseases
diseases
skin
Prior art date
Application number
BE187311A
Other languages
English (en)
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan filed Critical Univ Michigan
Publication of BE866611A publication Critical patent/BE866611A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)
BE187311A 1977-05-02 1978-05-02 Medicament contre les maladies de la peau BE866611A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/793,100 US4181725A (en) 1977-05-02 1977-05-02 Method for alleviating psoriasis

Publications (1)

Publication Number Publication Date
BE866611A true BE866611A (fr) 1978-09-01

Family

ID=25159088

Family Applications (1)

Application Number Title Priority Date Filing Date
BE187311A BE866611A (fr) 1977-05-02 1978-05-02 Medicament contre les maladies de la peau

Country Status (6)

Country Link
US (1) US4181725A (fr)
JP (1) JPS53136521A (fr)
AU (1) AU3543378A (fr)
BE (1) BE866611A (fr)
DE (1) DE2818553A1 (fr)
FR (1) FR2430228A1 (fr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5659710A (en) * 1979-10-22 1981-05-23 Eisai Co Ltd Preventive and remedy for psoriasis
AU538186B2 (en) * 1980-03-07 1984-08-02 Scotia Holdings Plc Prostaglandin precursors
US4451482A (en) * 1982-04-22 1984-05-29 Shell Oil Company Method of preventing or ameliorating pyrethroid skin sensory stimulation
US4788061A (en) * 1985-07-05 1988-11-29 Shore Ronald N Extended occlusive treatment of skin disorders
US5002974A (en) * 1988-04-04 1991-03-26 Warner-Lambert Co. Anesthetic/skin moisturizing composition and method of preparing same
US4861783A (en) * 1988-04-26 1989-08-29 E. I. Du Pont De Nemours And Company 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases
US4908162A (en) * 1988-11-22 1990-03-13 David Rubin Method of making triple bonded unsaturated fatty acids
SE8804214L (sv) * 1988-11-22 1990-05-23 Jean Cassuto Antiinflammatoriskt och antiinfektioest medikament
FR2664164A1 (fr) * 1990-07-04 1992-01-10 Texinfine Patrinove Composition dermatologique ou cosmetique.
GB9101986D0 (en) * 1991-01-30 1991-03-13 Smith & Nephew Pharmaceutical compositions
DE69208085T2 (de) * 1991-03-20 1996-11-14 Minnesota Mining & Mfg Strahlenhärtbare Vinyl/Silikon-Trennmittelüberzug
US5324746A (en) * 1993-02-12 1994-06-28 Mckee Rex N Method of treating damaged mucosal and epithelial tissues with misoprostol
CA2130291A1 (fr) * 1993-08-18 1995-02-19 Juan Carlos Mahiques Utilisation therapeutique des composes connus de types ester et amide
US5478837A (en) * 1994-06-07 1995-12-26 University Of Southern California Use of quinacrine in preventing adhesion formation
US6705323B1 (en) 1995-06-07 2004-03-16 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US6176240B1 (en) * 1995-06-07 2001-01-23 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
WO1998017231A2 (fr) * 1996-10-18 1998-04-30 Charous B Lauren Traitement et administration d'hydroxychloroquine
US6153197A (en) * 1996-12-18 2000-11-28 Albazi; Rakhi Topical treatment of psoriasis
US5994399A (en) * 1997-03-27 1999-11-30 Mckee; Rex N. Method of regenerating collagen-containing tissues with misoprostol
US5935137A (en) * 1997-07-18 1999-08-10 Gynecare, Inc. Tubular fallopian sterilization device
US6703384B2 (en) 1998-09-23 2004-03-09 Research Development Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
WO2000066107A2 (fr) * 1999-04-30 2000-11-09 Apt Pharmaceuticals, L.L.C. Nouvelles applications d'agents therapeutiques antipaludeens
WO2001028550A1 (fr) * 1999-10-15 2001-04-26 Mayo Foundation For Medical Education And Research Anesthesiques topiques employes dans le traitement du cancer, les affections auto-immunes et l'ischemie
US10179159B2 (en) * 1999-10-22 2019-01-15 Scott Wepfer Topical anesthetic formulation
US20020046357A1 (en) * 1999-12-28 2002-04-18 Jiandong Huang Software-based fault tolerant networking using a single LAN
CN1243000C (zh) * 2000-02-11 2006-02-22 研究发展基金会 生育酚、生育三烯酚、其它苯并二氢吡喃和侧链衍生物,及其用途
US20040214860A1 (en) * 2001-11-09 2004-10-28 Charous B. Lauren Method for treating inflammatory bowel disease
CA2466338C (fr) * 2001-11-09 2010-01-12 Lauren Charous Nouvelles utilisations pour des agents therapeutiques antipaludiques
US20040220220A1 (en) * 2001-11-09 2004-11-04 Charous B. Lauren Method for treating inflammatory bowel disease
US20040242632A1 (en) * 2001-11-09 2004-12-02 Charous B. Lauren Method for treating inflammatory bowel disease
AU2002361812B2 (en) * 2001-12-19 2007-11-08 Research Development Foundation Liposomal delivery of vitamin E based compounds
US20030236301A1 (en) * 2001-12-19 2003-12-25 Bob Sanders Liposomal delivery of vitamin E based compounds
RU2328273C2 (ru) * 2001-12-19 2008-07-10 Рисерч Дивелопмент Фаундейшн Липосомальная доставка соединений, основанных на витамине е
US20050159485A1 (en) * 2002-01-04 2005-07-21 Jost-Price Edward R. Combinations for the treatment of immunoinflammatory disorders and proliferative skin diseases
WO2003092617A2 (fr) * 2002-05-03 2003-11-13 Combinatorx, Incorporated Combinaisons destinees au traitement de troubles cutanes inflammatoires
US20040076671A1 (en) * 2002-10-21 2004-04-22 Aletha Tippett Methods and compositions for topical wound treatment
US6916627B2 (en) * 2002-11-27 2005-07-12 St. Jude Children's Research Hospital ATM kinase compositions and methods
US7108992B2 (en) * 2002-11-27 2006-09-19 St. Jude Children's Research Hospital ATM kinase compositions and methods
US7241746B2 (en) * 2003-08-06 2007-07-10 Regena Therapeutics, Lc Method and composition for treating periodontal disease
US9238127B2 (en) 2004-02-25 2016-01-19 Femasys Inc. Methods and devices for delivering to conduit
US8048086B2 (en) 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
US8052669B2 (en) 2004-02-25 2011-11-08 Femasys Inc. Methods and devices for delivery of compositions to conduits
US8048101B2 (en) 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
DE102004059613A1 (de) * 2004-12-10 2006-06-14 Liedtke, Rainer K., Dr. Zusammensetzung und Methode einer topischen Therapie von Neurodermitis
US20070023534A1 (en) * 2005-07-22 2007-02-01 Mingsheng Liu Water-source heat pump control system and method
US12171463B2 (en) 2008-10-03 2024-12-24 Femasys Inc. Contrast agent generation and injection system for sonographic imaging
US9554826B2 (en) 2008-10-03 2017-01-31 Femasys, Inc. Contrast agent injection system for sonographic imaging
US10070888B2 (en) 2008-10-03 2018-09-11 Femasys, Inc. Methods and devices for sonographic imaging
TWI881480B (zh) * 2015-06-30 2025-04-21 美商伊格集團國際股份有限公司 克立咪唑(clemizole)化合物於預防及治療肝癌之用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB859897A (en) * 1958-07-05 1961-01-25 Roche Products Ltd Novel unsaturated acids and esters thereof and a process for the manufacture and conversion of same
US3450821A (en) * 1967-03-02 1969-06-17 Hoffmann La Roche Stable compositions containing eicosatetrayn - (5,8,11,14) - oic-(1) acid and derivatives thereof
BE754114A (fr) * 1969-07-29 1971-01-29 Upjohn Co Nouveaux composes de la classe des prostaglandines et leur procede de preparation
US3903297A (en) * 1973-11-01 1975-09-02 Upjohn Co Method of treatment and prophylaxis of gastric hypersecretion and gastric and duodenal ulcers using prostaglandin analogs

Also Published As

Publication number Publication date
US4181725A (en) 1980-01-01
FR2430228A1 (fr) 1980-02-01
AU3543378A (en) 1979-11-01
DE2818553A1 (de) 1978-11-09
JPS53136521A (en) 1978-11-29

Similar Documents

Publication Publication Date Title
JPS53140889A (en) Device for supplying medicine to human or animal body
DE3067776D1 (en) Skin preparation device for the application of medical electrodes
SE7805954L (sv) Terapeutiska medel
IT1098199B (it) Prodotto farmaceutico per somministrazione vaginale
GB2083362B (en) Disposable heart valve unit
SE7808568L (sv) Kontinuerligt elektrokardiogramovervaknings- forfarande och -system for hjertpatienter
AT371996B (de) Kosmetisches behandlungsverfahren
JPS5441584A (en) Human body blood current meter
AU3543378A (en) Treating proliferative skin disease
DK22978A (da) Laegemiddelsproejte
IT7826703A0 (it) Dispositivo per coltivare cellule di tessuti animali e umani.
IT1106926B (it) Cannula per prelievo di sangue
GB2001528B (en) Artificial medical material with anticoagulative activity
IT1095356B (it) Oligopeptidi trifluorometilati,procedimento per la loro preparazione e loro applicazione terapeutica
IT7852054A0 (it) Prodotto per la cura della pelle
MX5489E (es) Mejoras en dispositivo para la administracion cutanea,de substancias medicamentosas
GB2003470B (en) Treatment of skin diseases
JPS5630918A (en) Medical composition for skin disease
FI782849A7 (fi) Terapeutiska medel
JPS5442893A (en) Preparation of bandage for medical treatment
ATA766577A (de) Kosmetisches mittel zum schutz der menschlichen haut
NL7800001A (nl) Werkwijze voor de bereiding van nieuwe chromoon- derivaten en de toepassing hiervan als genees- middel tegen hartziekten.
JPS53121707A (en) Agricultural medicine symmetrical nnsubstituted bisscarbamoyloxyiminodisulfide
JPS5441582A (en) Electrode for living body
NL7812403A (nl) Farmaceutisch preparaat voor de behandeling van diarree bij de mens.